# Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)

> **NCT00517907** · PHASE1 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 6 (estimated)

## Conditions studied

- Graft Vs Host Disease

## Interventions

- **DRUG:** Preimplantation factor (PIF-1)

## Key facts

- **NCT ID:** NCT00517907
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2015-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517907, "Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00517907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*